Leadership Team
Great Minds Think Differently
With a collective wealth of industry success, knowledge and drive, our leaders share a passion for reinvigorating healthcare.
Michael Graves
Interim Principal Executive Officer
Mike has served as a member of Eagle’s board of directors since 2013. Mike is Chairman of the board of directors of Nanocopoeia, Inc., and a member of the board of directors of RiboCor, Inc. Mike has a wide variety of pharmaceutical industry experience including his position as CEO and President of
Chris Krawtschuk
Chief Financial Officer
Chris joins Eagle from bluebird bio, where he served as CFO and Treasurer since 2022. He brings extensive experience in the pharmaceutical sector, having held numerous finance and treasury roles at Jubilant Pharma, Morphosys, and Pfizer.Chris began his financial career at PricewaterhouseCoopers.
Debra Hussain
Head of Commercial for Acute Care/Hospital
Debra joined Eagle as part of Eagle’s 2022 acquisition of Acacia Pharma with 25 years of pharmaceutical industry experience. As Chief Commercial Officer for Acacia, Debra had responsibility for BARHEMSYS® and BYFAVO®. Prior to Acacia, Debra spent 22 years at Eli Lilly and Company in positions of
Jeff Lovesy
Head of Commercial for Oncology
Jeff Lovesy brings over 25 years of executive leadership experience in specialty healthcare. As a recognized subject matter expert in specialty channel strategy, commercial operations, and patient services, Jeff has led high-impact teams and initiatives for industry-leading organizations.